HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Warnings In 2019, AERs In 2009: Touchstones Toward Homeopathic Guidance

Executive Summary

Priority enforcement areas listed in draft guidance note delivery formats other than oral and topical, such as nasal gel product that was early alarm in FDA's evaluation of safety and efficacy across homeopathic market. Recent warnings also noted in revised draft.

You may also be interested in...



Homeopathic Firm's Teething Remedy Touches FDA Enforcement Nerve

FDA warns OHM Pharma for promoting topical formula containing homeopathic ingredients as teething product for infants. The firm also warned about drug and supplements GMP violations and was an easy target for FDA following release of draft guidance outlining its enforcement priorities.

Latest Steps In FDA Homeopathy Policy Overhaul Prompt Trade Group Questions

A revised draft introduces list of risk-based enforcement priorities but doesn't necessarily tighten FDA oversight of homeopathics manufacturing and marketing, say CHPA and AIH.

Remediations For Three Homeopathic Firms, End Of Production For Another

FDA warning letters require lengthy remediation plans from Kadesh. and two of its contract manufacturers, Fill It Pack It and WePackItAll. The third manufacturer, US Continental Marketing, told FDA it has stopped making drugs.

Related Content

Topics

UsernamePublicRestriction

Register

RS149342

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel